|
UK's NICE turns down Glaxo Tyverb offer
Britain's healthcare cost effectiveness watchdog NICE has rebuffedGlaxoSmithKline's latest bid to get its drug Tyverb -- for womenwith advanced breast cancer -- into the state health system, thecompany said on Tuesday.
More... |
| All times are GMT -7. The time now is 01:50 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021